WCM Investment Management LLC Cuts Position in ICU Medical, Inc. (NASDAQ:ICUI)

WCM Investment Management LLC lowered its position in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 2.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 253,678 shares of the medical instruments supplier's stock after selling 5,803 shares during the quarter. WCM Investment Management LLC owned about 1.04% of ICU Medical worth $39,117,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Creative Planning raised its position in ICU Medical by 75.5% in the 2nd quarter. Creative Planning now owns 3,906 shares of the medical instruments supplier's stock worth $464,000 after purchasing an additional 1,680 shares during the period. Truist Financial Corp bought a new position in shares of ICU Medical during the second quarter valued at approximately $310,000. GAMMA Investing LLC raised its holdings in shares of ICU Medical by 83.6% in the third quarter. GAMMA Investing LLC now owns 571 shares of the medical instruments supplier's stock worth $104,000 after buying an additional 260 shares during the period. Hexagon Capital Partners LLC lifted its stake in shares of ICU Medical by 162.7% during the 3rd quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier's stock worth $36,000 after acquiring an additional 122 shares during the last quarter. Finally, OLD National Bancorp IN purchased a new position in ICU Medical during the 3rd quarter valued at $218,000. Institutional investors own 96.10% of the company's stock.

ICU Medical Stock Down 0.6 %

NASDAQ:ICUI traded down $0.87 during mid-day trading on Wednesday, reaching $156.94. The company's stock had a trading volume of 166,694 shares, compared to its average volume of 199,100. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. The firm has a market capitalization of $3.84 billion, a PE ratio of -34.34 and a beta of 0.63. The stock has a fifty day moving average of $160.73 and a 200-day moving average of $164.16. ICU Medical, Inc. has a 1 year low of $93.36 and a 1 year high of $196.26.

Insider Transactions at ICU Medical

In related news, CEO Vivek Jain sold 12,000 shares of the company's stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $162.91, for a total value of $1,954,920.00. Following the sale, the chief executive officer now owns 104,593 shares in the company, valued at $17,039,245.63. This represents a 10.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Christian B. Voigtlander sold 1,962 shares of the firm's stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $169.08, for a total transaction of $331,734.96. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 17,737 shares of company stock worth $2,879,752. Insiders own 6.70% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms have weighed in on ICUI. KeyCorp increased their target price on ICU Medical from $198.00 to $209.00 and gave the stock an "overweight" rating in a research note on Wednesday, November 13th. Jefferies Financial Group raised shares of ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price objective for the company in a research report on Wednesday, December 11th. StockNews.com raised shares of ICU Medical from a "hold" rating to a "buy" rating in a research report on Wednesday, November 20th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a report on Wednesday, November 13th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, ICU Medical currently has a consensus rating of "Moderate Buy" and an average price target of $199.67.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.